The non-invasive screening tool for cancer detection in for lumps and bumps in canine introduces groundbreaking new functionality.
With the latest version of HT Vista, not only can cancer be ruled out without the need for invasive procedures, but with a specificity of over 90%, the system also offers diagnostic functionality.
In addition to further improvements in operation and the scanning process, the 4.0 update includes a better display of the cancer risk and, for the first time, eine AI-supported diagnostic functionality for common tumor types without invasive procedures!
Advances in the programming of algorithms and artificial intelligence (AI) as well as the growing volume of validated data from studies, which has now grown to 1’163 masses, have paved the way for two significant new functions in version 4.0:
- Assessment of the cancer risk: Visualization of cancer risk in three levels, provides better decision support and assistance for quick assessment of lumps and nodules immediately after examination. It helps decision making by identifying low risk cases that can be safely monitored and recommending next steps for medium and high risk cases.
- AI-supported tumor subclassification: Following the cancer risk assessment, a diagnosis of benign tumors such as lipomas and malignant tumors such as mast cell tumors (MCTs) is made. In all cases where HT Vista determines a very low or very high probability of malignancy - a diagnosis of the tumor type is made from a specificity of 90%. This avoids unnecessary invasive procedures for benign lipomas and enables the early detection of MCTs.
An official briefing is planned for March 20, 2025 to explain the features and benefits of the program in more detail. Dr. Liron Levy-Hirsch MD DVM MRCVS of HT Vista, Europe:
"We are incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system. Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumor types, we are taking another significant step forward. This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes. By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
Mrs Shani Toledano, CEO and Co-Founder from HT Vet – HT BioImaging:
“The latest HT Vista upgrade transforms cancer detection in veterinary medicine. With enhanced diagnostic capabilities and 90%+ specificity, we empower vets to detect malignancies earlier—without invasive procedures. This breakthrough sets a new standard in veterinary diagnostics, saving more lives with greater confidence.”
Read more in the HT Vista blog: https://blog.ht-vet.com/blog/ht-vista-in-dvm360-non-invasive-cancer-screening-for-lumps-bumps-0
Would you like to learn more about HT Vista?
Send us an e-mail to:
